Keyphrases
Heparin
100%
Acute Coronary Syndrome
100%
Unfractionated Heparin
100%
Invasive Management
100%
Bivalirudin
100%
Glycoprotein IIb/IIIa Inhibitors
88%
Access Site
55%
Major Adverse Cardiovascular Events
44%
Net Adverse Clinical Events
33%
Myocardial Infarction
22%
Bleeding
22%
Hemorrhagic Disease
22%
Transradial Access
22%
Major Bleeding
11%
Sensitivity Analysis
11%
Intra-procedural
11%
3-group
11%
Stent Thrombosis
11%
Bleeding Complications
11%
Transfusion Rate
11%
Event Rate
11%
Comparative Efficacy
11%
Coronary Intervention
11%
Surgical Access
11%
Comparative Safety
11%
Co-primary Endpoints
11%
INIS
patients
100%
coronaries
100%
management
100%
heparin
100%
glycoproteins
80%
matrices
20%
comparative evaluations
20%
safety
20%
myocardial infarction
20%
implementation
20%
doses
10%
surgery
10%
mortality
10%
transfusions
10%
interventions
10%
thrombosis
10%
death
10%
repair
10%
foundations
10%
adjustments
10%
sensitivity analysis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Heparin
100%
Acute Coronary Syndrome
100%
Bivalirudin
100%
Fibrinogen Receptor
80%
Cardiovascular Disease
40%
Bleeding
30%
Heart Infarction
20%
Cerebrovascular Accident
20%
Ciclonicate
10%
Stent Thrombosis
10%
Medicine and Dentistry
Heparin
100%
Acute Coronary Syndrome
100%
Bivalirudin
100%
Glycoprotein IIb/IIIa Inhibitors
80%
Cardiovascular Disease
40%
Myocardial Infarction
20%
Apoplexy
20%
Bleeding
20%
Ciclonicate
10%
Major Bleeding
10%
Stent Thrombosis
10%